Edition 30 – Ending the Opioid Crisis in Five Years
Ending the Opioid Crisis in Five Years By Kelly O’Connor Citation O’Connor K. Ending the opioid crisis in five years. HPHR. 2021; 30. DOI:10.54111/0001/DD27 Ending the Opioid Crisis in Five Years Introduction In 2017, 70,237 people died from drug overdose; my little sister Jenny was just one of them. I watched her die from prescription […]
Edition 25 – Buprenorphine Prior Authorization Removal: Low Hanging Fruit in the Opioid Overdose Crisis
Buprenorphine Prior Authorization Removal: Low Hanging Fruit in the Opioid Overdose Crisis By Tamara Beetham Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Beetham T. Buprenorphine prior authorization removal: low hanging fruit in the opioid overdose crisis. Harvard Public Health Review. 2019;25. DOI:10.54111/0001/Y2 Buprenorphine Prior Authorization Removal: Low Hanging Fruit […]
Edition 25 – Tackling the Opioid Epidemic: Using the Enhanced Recovery After Surgery Principles to Manage Gynecological Post-Op Pain
Tackling the Opioid Epidemic: Using the Enhanced Recovery After Surgery Principles to Manage Gynecological Post-Op Pain By Kimia Etemadi Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Etemadi K. Tackling the opioid epidemic: using the enhanced recovery after surgery principles to manage gynecological post-op pain. Harvard Public Health Review. 2019;25. […]
Edition 25 – Purdue Pharma and OxyContin – A Commercial Success But Public Health Disaster
Purdue Pharma and OxyContin – A Commercial Success But a Public Health Disaster By Ronald Chow Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Chow R. Purdue Pharma and OxyContin – a commercial success but public health disaster. Harvard Public Health Review. 2021; 28. DOI:10.54111/0001/Y5 Purdue Pharma and OxyContin – […]
